TJ
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Tajikistan
Medical Only (Private)
Reimbursed Care Access
Tajikistan maintains a strict, enforcement-focused national drug-control regime with the Drug Control Agency under the President coordinating counter‑narcotics activity and UNODC cooperation. Standard medical use of ketamine as an essential anaesthetic is recognized in international and national practice, but novel psychedelic medicines (psilocybin, MDMA, esketamine as a licensed antidepressant, DMT/5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, and 2C‑X) have no routine authorised medical reimbursement pathways and are effectively unavailable outside tightly regulated research or are subject to criminal control and seizure operations.
No clinical trials found for this country yet.